Updated: Oct 16
In 2011, while the US and the world were riveted by headlines of a second mass shooting at Virginia tech, the meltdown at the Fukushima nuclear plant, and the death of Moammar Gadhafi, most Americans could never imagine what was playing out behind the scenes. Jon Stryker, the heir to a medical fortune and founder of Arcus Foundation, the most potent LGBT non-governmental organization (NGO) in the U.S., fed by Stryker’s stock in his family's medical empire, was building a powerful infrastructure to drive the normalization and institutionalization of synthetic sex identities, the first medical identities.
In 2014, Time Magazine published a cover photo and feature of actor Laverne Cox, a man posing as a woman. Cox was purportedly ushering in a “transgender tipping point.” He'd had multiple surgeries to change the appearance of his secondary sex characteristics and was dressed in culturally ascribed feminine attire; long hair, make-up, a dress, and heels. Though Cox was to be exhibit “A” of a transgender tipping point, before this date, "transgenderism," morphing quickly to "gender identity," was not at the forefront of most people’s minds, so there was nothing evident that preceded that moment which would constitute a “tipping point” having been reached.
Yet, suddenly, "gender identity" was everywhere – as if something had been generated behind the scenes (there was). Six years later, we had "transgender celebrities," "transgender athletes," "transgender CEOs," "transgender health coverage," and "transgender students." Language emerged specific to these individuals, laws rearranging reality for the rest of the world to accommodate them, new school curriculums for children and adults, new medical protocols, hormone availability, chest binders, packers, youth gender clinics, camps, modeling agencies and beauty products, etc., arrived on our social landscape like a nuclear assault - all for a tiny fraction of the population with an issue that has no known medical cause. "Transgenderism" is the first “medical condition” reported to cause intense body dysphoria for many (significantly as it impacts children) that is simultaneously promoted as identity and being celebrated throughout western cultures.
This is the first time in history that body dysphoria of any sort has been promoted as something to celebrate and as a medical identity in what is shaping up to be a prolific industry. People who identify as a sex other than their own, young women who have had voluntary double mastectomies of their healthy breasts, are being used in corporate advertising to sell everything from underwear to shaving cream. Behemoth Law and media conglomerates create amicus briefs and legal support guides to drive the normalization process. Lawyers are being trained worldwide, and global organizations are built for the specific task of normalizing this medical identity.
Who profits? The obvious answer is the medical-industrial complex, with lifelong patients needing drugs and surgeries. These people will suffer the consequences of these drugs and surgeries as they age. Still, the medical-industrial complex is not the only industry invested in normalizing and preparing for the growth of medical identities. In 2011, while America was thinking about other things, Yvette Burton was brought to Arcus Foundation as its new chief executive officer. For over a decade, Burton was a managing global business development executive, business transformation strategist, and market development research director for IBM’s Sales and General Business Services divisions. She has also led IBM’s commercial strategy for global LGBT partnerships and advised numerous multinational companies on their internal and external outreach to the LGBT community.
Before Laverne Cox’s Time Cover announcement of a “transgender tipping point,” Arcus Foundation was driving the normalization of this new medical identity, under the banner of LGB civil rights, not only into our institutions, legal and political structures but also into the marketplace.
With the guidance of the Arcus Foundation, hundreds of companies have continued to expand inclusion for individuals identifying as transgender across corporate America. Over 80 percent of the Fortune 500 have explicit gender identity protections; two-thirds have "gender-inclusive" healthcare coverage; hundreds have LGBTQ+ and Allies business resource groups and internal training efforts. Of course, there is the issue of public bathrooms.
In 2016 North Carolina attempted to hold onto their sex-specific public restrooms. HRC, the gender lobby group, engaged 206 corporations worth trillions of dollars to roll back the state's bill. The bill (HB2) called for the continued protection and safety of women and girls via sex-specific bathrooms. The gender lobby was able to curry the favor of significant corporations toward less than one percent of the population who desire to be seen as the opposite sex, who increasingly reject biological reality in favor of a political ideology causing untold harm across many western cultures.
We are witnessing the birth of an industry, one that rejects biological reality. If we continue allowing this social engineering, we can expect other medical identities to emerge, identities that will need medical and technological interventions for life to exist. These identities will be protected by laws that are now being implemented, purportedly to protect feelings, but are, in reality, legally deconstructing biological sex and what it means to be human.
See here for a visual list of corporations investing in normalizing new medical identities and corporate investment in the Gender Identity industry.
This research depends on the generosity of readers. If you like what you are reading on the 11th-hour blog, please consider a donation or paid subscription in support. Use this link for donations. Thank you.